Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
434.30    -0.90 (-0.21%)
Bid:
436.00
Ask:
436.10
Spread: 0.10 (0.023%)
Market Cap: £10.93b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Result of AGM

7 May 2025 16:15

RNS Number : 7517H
Rentokil Initial PLC
07 May 2025
 

RENTOKIL INITIAL PLC

 

RESULTS OF ANNUAL GENERAL MEETING 2025 ('AGM')

 

At the AGM of Rentokil Initial plc duly convened and held at, and broadcast from, the Company's offices at Compass House, Manor Royal, Crawley, West Sussex, RH10 9PY on 7 May 2025 at 2:00pm, each resolution as set out in the notice of meeting dated 26 March 2025 was passed on a poll. The results are set out below and will be placed on the Company website at www.rentokil-initial.com/investors.

 

RESOLUTION

VOTES FOR1

%

VOTES AGAINST

%

TOTAL VOTES

% of ISC VOTED

VOTES WITHHELD2

1

To receive the audited financial statements and the directors' and auditors' report thereon

2,220,150,879

99.99

268,425

0.01

2,220,419,304

87.95

9,348,399

2

To approve the Directors' Remuneration Report

2,131,852,759

95.81

93,234,712

4.19

2,225,087,471

88.14

4,680,233

3

To declare a final dividend

2,229,115,428

99.99

158,105

0.01

2,229,273,533

88.30

494,171

4

To re-elect Richard Solomons as a director3

1,756,956,118

78.85

471,172,370

21.15

2,228,128,488

88.26

1,639,214

5

To re-elect Andy Ransom as a director

2,083,824,855

93.48

145,350,701

6.52

2,229,175,556

88.30

592,147

6

To elect Paul Edgecliffe-Johnson as a Director

2,076,608,612

98.79

25,333,839

1.21

2,101,942,451

83.26

127,825,252

7

To elect Brian Baldwin as a Director

2,056,741,191

97.85

45,202,964

2.15

2,101,944,155

83.26

127,823,549

8

To re-elect David Frear as a Director

2,056,512,211

97.84

45,437,341

2.16

2,101,949,552

83.26

127,818,151

9

To re-elect Sally Johnson as a director

2,054,479,980

97.74

47,559,680

2.26

2,102,039,660

83.26

127,728,043

10

To re-elect Sarosh Mistry as a director

2,055,771,195

97.80

46,172,264

2.20

2,101,943,459

83.26

127,824,244

11

To re-elect John Pettigrew as a director

2,057,736,665

97.90

44,204,999

2.10

2,101,941,664

83.26

127,826,039

12

To re-elect Cathy Turner as a director

2,055,868,665

97.80

46,171,247

2.20

2,102,039,912

83.26

127,727,791

13

To re-elect Linda Yueh as a director

2,012,154,466

95.72

89,886,457

4.28

2,102,040,923

83.26

127,726,779

14

To re-appoint PricewaterhouseCoopers LLP as auditor

2,228,111,667

99.94

1,241,051

0.06

2,229,352,718

88.31

414,986

15

To authorise the directors to agree the auditors' remuneration

2,228,274,501

99.95

1,075,702

0.05

2,229,350,203

88.31

417,501

16

To authorise the making of political donations

2,214,198,854

99.65

7,841,820

0.35

2,222,040,674

88.02

7,727,030

17

To authorise the directors to allot shares

2,129,872,686

95.62

97,483,118

4.38

2,227,355,804

88.23

2,411,900

18

To disapply statutory pre-emption rights

2,068,968,078

92.92

157,743,661

7.08

2,226,711,739

88.20

3,055,965

19

To disapply statutory pre-emption rights for acquisitions and specified capital investments

1,972,920,831

88.58

254,284,896

11.42

2,227,205,727

88.22

2,561,977

20

To authorise the Directors to make market purchases of the Company's own shares

2,228,053,853

99.98

407,466

0.02

2,228,461,319

88.27

1,306,385

21

To authorise the calling of a general meeting (other than an annual general meeting) on 14 days' clear notice.

2,115,308,575

94.88

114,050,423

5.12

2,229,358,998

88.31

408,706

 

1. Votes For include those votes giving the Chair discretion.

2. A vote withheld is not a vote in law and is not counted in the calculation of proportion of votes cast for or against a resolution.

3. The Board notes that over 20% of votes cast were against the Board's recommendation in respect of resolution 4. The Board will continue to engage proactively with shareholders to ensure their views are understood in respect of the re-election of Richard Solomons. In accordance with provision 4 of the UK Corporate Governance Code, the Board will provide an update on this engagement within 6 months of the AGM, as well as a final summary in the Company's 2025 Annual Report and Accounts.

 

The number of ordinary shares in issue at close of business on 6 May 2025 was 2,524,539,885 ordinary shares of 1p each. Resolutions 18 to 21 were proposed as special resolutions. A copy of the resolutions can be found in the Notice of Meeting available at www.rentokil-initial.com/agm.

 

A copy of the resolutions passed concerning special business has been submitted and will shortly be available for inspection at the National Storage Mechanism located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

Enquiries:

 

Group General Counsel and Company Secretary:

 

Rachel Canham

 

Rentokil Initial plc

 

+44 (0)1293 858000

Media:

Malcolm Padley

Rentokil Initial plc 

+44 (0)1293 858000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSMFIWEISESI
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.